
Udayam Pharmaceuticals Private Limited
About Udayam Pharmaceuticals Private Limited
Data last updated:
Udayam Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74900TN2013PTC092755. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Nangamangalam Kandhadai Vasantha and Nangamangalam Kandhai Giridharan.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at A – 1 Bajanai Koil Street Ground Floor Melayanambakkam, Chennai, Tamil Nadu, India – 600095.
As per the financials filed for FY 2018, the company reported a revenue of ₹3.84 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.21 Lakh (net margin 0.3%) and EBITDA of ₹14.04 Lakh (EBITDA margin 3.7%).
As per MCA filings, the company has open charges of ₹65 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Udayam Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 1 Bajanai Koil Street Ground Floor Melayanambakkam, Chennai, Tamil Nadu, India – 600095
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Udayam Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Udayam Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Udayam Pharmaceuticals Private Limited, buy the company report.
Financials of Udayam Pharmaceuticals Private Limited
FY 2018 filings availableUdayam Pharmaceuticals Private Limited reported revenue of ₹3.84 Cr (down 2% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year. EBITDA rose 45% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹3.84 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹14.04 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.21 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.7% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Udayam Pharmaceuticals Private Limited, buy the company report.
Board of directors of Udayam Pharmaceuticals Private Limited
Udayam Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nangamangalam Kandhadai Vasantha Also directs: Teja Pharma Private Limited | Director | 26 Sep 2018 | 8 Years 1 Months | Current |
| Nangamangalam Kandhai Giridharan Also directs: Annamalayar Medicals Private Limited, Teja Pharma Private Limited | Director | 28 Jan 2016 | 10 Years 9 Months | Current |
Peer comparison
Udayam Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Winston Pharmaceuticals Limited | ₹3.85 Cr (FY 2023) | -21.0% | Aurangabad, Maharashtra, India | |||
| BCM Healthcare Private Limited | ₹3.85 Cr (FY 2025) | 89.0% | Ahmedabad, Gujarat, India | |||
| Elegant Distributors Private Limited | ₹3.84 Cr (FY 2024) | 7.0% | Delhi, India | |||
| Udayam Pharmaceuticals Private Limitedthis company | ₹3.84 Cr (FY 2018) | ₹1.21 Lakh | 0.3% | -2.0% | Chennai, Tamil Nadu, India | |
| Satyam Medicare Private Limited | ₹3.84 Cr (FY 2018) | Thane, Maharashtra, India | ||||
| Yew Pharma Private Limited | ₹3.84 Cr (FY 2025) | -2.0% | Rajkot, Gujarat, India |
To see the full peer comparison of Udayam Pharmaceuticals Private Limited, buy the company report.
Auditor
Udayam Pharmaceuticals Private Limited is audited by W GOWRI & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| W GOWRI & ASSOCIATES | FY 2018 | 018130S |
Shareholding
The shareholding of Udayam Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Udayam Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Apr 2016 | 100045636 | City Union Bank Limited | ₹65 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Udayam Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Udayam Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Udayam Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Udayam Pharmaceuticals Private Limited, buy the company report.
Recent activity
Udayam Pharmaceuticals Private Limited has 8 board changes on record since 2014: 2 appointments and 6 cessations. The latest: Nangamangalam Kandhadai Vasantha was appointed as Director on 26 Sep 2018.
Frequently asked questions
Udayam Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 August 2013 (13+ years old) and is registered under CIN U74900TN2013PTC092755.
Udayam Pharmaceuticals has 2 current directors:
- Nangamangalam Kandhadai Vasantha - Director
- Nangamangalam Kandhai Giridharan - Director
The latest financial statements of Udayam Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.
No. Udayam Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Udayam Pharmaceuticals is U74900TN2013PTC092755. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Udayam Pharmaceuticals was incorporated on 29 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Udayam Pharmaceuticals by revenue are Winston Pharmaceuticals Limited, BCM Healthcare Private Limited, Elegant Distributors Private Limited, Satyam Medicare Private Limited, Yew Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Nangamangalam Kandhadai Vasantha was appointed as Director on 26 Sep 2018. Rathinam Suresh Kumar ceased to be Director on 26 Sep 2018. Mohanbabu ceased to be Director on 27 Feb 2017. Udayam Pharmaceuticals has 8 board changes on record in total.
The registered office of Udayam Pharmaceuticals is at A – 1 Bajanai Koil Street Ground Floor Melayanambakkam, Chennai, Tamil Nadu, India – 600095.
Udayam Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Udayam Pharmaceuticals has open charges of ₹65 Lakh and no satisfied charges on record as per latest MCA filings.

